2026-08-11Bullish
+10.64%weekly changeVertex rose on strong Q2 earnings, raised full-year guidance, and the trial failure of a key rival's cystic fibrosis drug candidate.
read the report →← every name covered
S&P 500
VRTX
Vertex Pharmaceuticals Incorporated
latest move
+10.64%
2026-08-11
1 session · 2026-08-11 · avg 10.64% · largest 10.64%
Vertex Pharmaceuticals Incorporated is a global biotechnology leader that discovers, develops, and commercializes small-molecule drugs and genetic therapies for serious diseases.